 Baltimore Sun |
FDA panel backs previously rejected obesity pill
The Associated Press SILVER SPRING, Md. (AP) — A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the US … FDA panel overwhelmingly backs previously rejected anti-obesity pill Qnexa US advisers back experimental obesity pill |
 USA TODAY |
Judge: Washington state cannot force pharmacies to sell 'morning after' pill
Seattle Post Intelligencer Judge to rule if pharmacies must sell "Plan B" pills Judge says Wash. can't make pharmacies sell Plan B |
 LifeNews.com |
Court says pharmacists can't be forced to dispense morning-after pill
Washington Post (blog) 22) struck down a Washington state rule that requires pharmacists to dispense the morning-after pill even if it violates their religious beliefs. Religious liberty advocates cheered the decision. They have decried the 2007 state regulation as a … Federal judge strikes down Washington state's morning-after pill mandate |
Related posts:
- Panel Backs Approval Of Longer-Acting ‘Pill’ – NPR
- FDA panel backs overall benefit of Yaz pills – USA Today
- Pharmacists Can Refuse to Sell ‘Plan B’
- Plan to Widen Availability of Morning-After Pill Is Rejected – New York Times
- FDA panel backs birth control patch despite risks – BusinessWeek